Reilly Paul J
Known title: DirectorCIK: 0001186378
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 7, 2026
Analysts Raise AIZN Price Target 13.72% to $19.99. Analysts have raised the consensus price target for Assurant's 2061 subordinated notes by 13.72% to $19.99, suggesting improving sentiment toward the insurer's credit outlook. The notes currently trade near support at $19.09 with an RSI of 28.6, indicating technical oversold conditions. This upward revision in price targets may reflect views that the notes are undervalued at current levels.
Transaction History
| AIZ | ▲ Buy | Grant | 668 | $0 | 5/22/2026 | View on chart |
| AIZN | ▲ Buy | Grant | 881 | $0 | 5/22/2025 | View on chart |
| AIZN | ▲ Buy | Grant | 947 | $0 | 5/24/2024 | View on chart |
| AIZN | ▲ Buy | Grant | 1,235 | $0 | 5/12/2023 | View on chart |
| AIZN | ▲ Buy | Grant | 881 | $0 | 5/13/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Assurant Launches Chile Protection Offering Amid Valuation Debate
Assurant announced a new protection offering in Chile, adding a new market to its portfolio. Analysts note that the stock has risen 20.1% over the past year, yet some view it as undervalued compared to a target of $330. The company also continues to expand in reinsurance and energy risk, while its dividend yield sits at 1.74%.
Assurant Launches Chile Protection Offering Amid Valuation Debate. Assurant announced a new protection offering in Chile, adding a new market to its portfolio. Analysts note that the stock has risen 20.1% over the past year, yet some view it as undervalued compared to a target of $330. The company also continues to expand in reinsurance and energy risk, while its dividend yield sits at 1.74%.